Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Briana Ndife
ResearcherPublications, citations & collaboration network
Briana Ndife is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 86 works, 217 citations, an h-index of 9 and an i10-index of 8.
86
Works
217
Citations
9
h-index
8
i10-index
IDs:OpenAlex
How has Briana Ndife's publication output changed over time?
ScholarIQpublication output · 2018–2026
Output declined80% over the shown period — from 5 works in 2018 to 1 in 2026.
5
3
2
1
2018201920222026
What are the most-cited papers on Briana Ndife?
ScholarIQmost cited works
Targeted Agents or Immuno-Oncology Therapies as First-Line Therapy for BRAF-Mutated Metastatic Melanoma: A Real-World Study
Jason J. Luke, Sameer R. Ghate, Jonathan Kish, Choo Hyung Lee, Lindsay McAllister, Sonam Mehta, Briana Ndife, Bruce A. Feinberg
Future Oncology. 201938 CitationsOPEN ACCESS
Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma
Ahmad A. Tarhini, Sameer R. Ghate, Raluca Ionescu‐Ittu, Ameur M. Manceur, Briana Ndife, Philippe Jacques, François Laliberté, Antônio Nakasato, Rebecca Burne, Mei Sheng Duh
S3207524. 201831 CitationsOPEN ACCESS
Patient Preferences for Treatment of Metastatic Melanoma
Carol Mansfield, Briana Ndife, Joyce Chen, Kathleen Gallaher, Sameer R. Ghate
Future Oncology. 201921 CitationsOPEN ACCESS
Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States
Karen Seiter, Dominick Latrémouille-Viau, Annie Guérin, Briana Ndife, Karen Habucky, Derek Tang, Irina Pivneva, Patrick Gagnon‐Sanschagrin, George J Joseph
Advances in Therapy. 201817 Citations
Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States
Eytan M. Stein, Jipan Xie, Emilie D. Duchesneau, S. Bhattacharyya, Umakanth Vudumula, Briana Ndife, Gaetano Bonifacio, Annie Guérin, Nanxin Li, George Joseph
PharmacoEconomics. 201814 Citations
Related on ScholarIQ
Novartis (Switzerland)
Institution
Targeted Agents or Immuno-Oncology Therapies as First-Line Therapy for BRAF-Mutated Metastatic Melanoma: A Real-World Study
Paper
Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma
Paper
Patient Preferences for Treatment of Metastatic Melanoma
Paper
Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States
Paper
Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States
Paper